US · Healthcare · Medical Care Facilities
EPS came in at 0.32 against a street estimate of 0.31 — a beat of 3.2%.
Analysts rate Pennant Group Inc a buy (2 buy, 2 hold, 0 sell out of 4) with an average price target of $45.00.
| Fund | Stake |
|---|---|
| Van Berkom and Associates Inc | 15.36% |
| BlackRock Inc | 7.81% |
| Wasatch Advisors LP | 5.38% |
| Turtle Creek Asset Management Inc. | 4.55% |
| Vanguard Capital Management, LLC | 4.17% |
| Paradigm Capital Management, Inc. | 4.05% |
| FMR Inc | 3.17% |
| Seger Elvekrog Inc | 2.83% |
| Document | Date |
|---|---|
| Shareholder vote results · Q2 2026 | 2026-05-20 |
| Quarterly report · Q1 2026 | 2026-05-06 |
| Results announced · Q2 2026 | 2026-05-06 |
| Proxy statement · Q2 2026 | 2026-03-31 |
| Annual report FY2025 | 2026-02-26 |
| Results announced · Q1 2026 | 2026-02-25 |
| Material agreement · Q4 2025 | 2025-11-05 |
| Quarterly report · Q3 2025 | 2025-11-05 |
Readable in the app.
Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Pennant Group Inc — free to start.
Google PlayApp StoreData updated 2026-08-05.